Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Barriers to the Implementation of Complete Insulin Order Sets

This study has been completed.
International Diabetes Center at Park Nicollet
Park Nicollet Foundation
Information provided by:
HealthPartners Institute Identifier:
First received: December 19, 2008
Last updated: November 25, 2015
Last verified: December 2008
The major purpose of this Quality Improvement project is to begin to address the issues surrounding glycemic control in the hospital setting by collecting accurate, reliable and verifiable data on the occurrence of hyperglycemia (BG >300 mg/dL), and whether or not CIO is used (immediately before and 72 hours after the BG >300 mg/dl).


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Barriers to the Implementation of Complete Insulin Order Sets in the Management of Individuals With Hyperglycemia or Diabetes at Park Nicollet Methodist Hospital

Resource links provided by NLM:

Further study details as provided by HealthPartners Institute:

Primary Outcome Measures:
  • glucose levels [ Time Frame: 72 hours ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • type of insulin treatment [ Time Frame: 72 hours ] [ Designated as safety issue: Yes ]

Enrollment: 200
Study Start Date: June 2008
Study Completion Date: December 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
hospitalized patients with BG >300 ml/dL


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
hospitalized patients with blood glucose >300 mg/dL

Inclusion Criteria:

  • Park Nicollet Methodist Hospital patient
  • recorded BG > 300 mg/dL during the study data collection period
  • admitted to general floor hospital units

Exclusion Criteria:

  • birth center
  • intensive care units
  • eating disorder unit
  • pediatric patients < 18 years of age
  • patients receiving insulin infusions
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00813280

United States, Minnesota
Park Nicollet Methodist Hospital
Minneapolis, Minnesota, United States, 55416
Sponsors and Collaborators
HealthPartners Institute
International Diabetes Center at Park Nicollet
Park Nicollet Foundation
Principal Investigator: Lisa Fish, MD Park Nicollet Health Services Endocrinology
Principal Investigator: Robert M Cuddihy, MD International Diabetes Center at Park Nicollet
  More Information

Responsible Party: Lisa Fish, MD Identifier: NCT00813280     History of Changes
Other Study ID Numbers: 03735-08-A 
Study First Received: December 19, 2008
Last Updated: November 25, 2015
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Glucose Metabolism Disorders
Metabolic Diseases processed this record on October 27, 2016